A Multi‐action Pt IV Conjugate with Oleate and Cinnamate Ligands Targets Human Epithelial Growth Factor Receptor HER2 in Aggressive Breast Cancer Cells-Reference-Cited by-同舟云学术

A Multi‐action Pt IV Conjugate with Oleate and Cinnamate Ligands Targets Human Epithelial Growth Factor Receptor HER2 in Aggressive Breast Cancer Cells

Published:2020-09-08 Issue:47 Volume:132 Page:21343-21348
ISSN:0044-8249
Container-title:Angewandte Chemie
language:en
Short-container-title:Angew. Chem.

Author:

Kostrhunova Hana¹^ORCID,Zajac Juraj¹,Markova Lenka¹^ORCID,Brabec Viktor¹^ORCID,Kasparkova Jana¹^ORCID

Affiliation:

1. Czech Academy of Sciences Institute of Biophysics Kralovopolska 135 61265 Brno Czech Republic

Funder

Grantová Agentura České Republiky

Publisher

Wiley

Subject

General Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/ange.202009491

Reference38 articles.

1. Targeted therapeutic options and future perspectives for HER2-positive breast cancer

2. Discovery and development of pyrotinib: A novel irreversible EGFR/HER2 dual tyrosine kinase inhibitor with favorable safety profiles for the treatment of breast cancer

3. Induction of targeted necrosis with HER2-targeted platinum(iv) anticancer prodrugs

4. The Molecular Biology of HER2 and HER2-Targeted Therapies

5. Platinum–Taxane Combinations in Metastatic Breast Cancer: An Evolving Role in the Era of Molecularly Targeted Therapy

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Platinum(IV) and platinum(II) anticancer complexes with biologically active releasable ligands;Coordination Chemistry Reviews;2024-02

2. Unveiling the multifaceted antiproliferative efficacy of Cichorium endivia root extract by dual modulation of apoptotic and inflammatory genes, inducing cell cycle arrest, and targeting COX-2;RSC Advances;2024

3. Chiral Ru ^II ‐Pt ^II Complexes Inducing Telomere Dysfunction against Cisplatin‐Resistant Cancer Cells;Angewandte Chemie International Edition;2022-07-07

4. Chiral Ru ^II ‐Pt ^II Complexes Inducing Telomere Dysfunction against Cisplatin‐Resistant Cancer Cells;Angewandte Chemie;2022-07-07

5. Design concepts of half-sandwich organoruthenium anticancer agents based on bidentate bioactive ligands;Coordination Chemistry Reviews;2021-10